Trial reportJournal of the American Heart Association2019
Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT.
Trial report in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00000542. Cited by 59 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Who cites it
59 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.
- Impact of Social Determinants of Health on Hypertension Outcomes: A Systematic Review.Hypertension (Dallas, Tex. : 1979) · 2024Pooled it
- A Teaching Kitchen Medical Groups Visit with an eHealth Platform for Hypertension and Cardiac Risk Factors: A Qualitative Feasibility Study.Journal of alternative and complementary medicine (New York, N.Y.) · 2021Trial
- Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT.Journal of the American Heart Association · 2019Trial
- Individual income and blood pressure control after antihypertensive treatment initiation accounting for regional variation: a Japanese nationwide study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Gaining Community Trust Enables Research Designed to Reduce the National Burden of Chronic Kidney Disease.Journal of immigrant and minority health · 2026Review
- Evaluation of Real-World Patient Engagement in a Remote Patient Monitoring for Hypertension Program.Journal of general internal medicine · 2026Article
- Inequities in the Hypertension and Diabetes Care Cascade: A Comparison of SES and Insurance in China, the US, and the UK.Healthcare (Basel, Switzerland) · 2026Article
- Metabolic Risk-attributable Burden of Peripheral Arterial Disease across Socioeconomic Regions: Insights from the Global Burden of Disease Study 2021.Current cardiology reviews · 2026Review
- Global, Regional, and National Burden and Trends of Hypertensive Heart Disease Among Women of Childbearing Age from 1992 to 2021.International journal of women's health · 2026Article
- A Comprehensive Review of Acute Type A Aortic Dissection: Epidemiology, Classification, Management Strategies, Mortality Risk Assessment, and Ethical Considerations for Patients who Refuse Blood Transfusions.Reviews in cardiovascular medicine · 2025Review
- English- and Spanish-Speaking Patient Preferences on Home Blood Pressure Monitors in an Urban Safety Net Setting: Qualitative Study.JMIR cardio · 2025Article
- Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: A Scoping Review.Journal of general internal medicine · 2025Article
- Association between equivalized annual household income and regular medical visits for hypertensive patients since the COVID-19 outbreak.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- Variation in Hypertension Control by Race and Ethnicity, and Geography in US Veterans.Journal of the American Heart Association · 2025Article
- Global and national burden of peripheral arterial disease from 1990 to 2021: a systematic analysis of global burden of disease study 2021.Frontiers in cardiovascular medicine · 2025Article
- Accessibility and quality of care for adults with hypertension in rural Burkina Faso: results from a cross-sectional household survey.PLOS global public health · 2025Article
- Pathways From Socioeconomic Factors to Major Cardiovascular Events Among Postmenopausal Veteran and Nonveteran Women: Findings From the Women's Health Initiative.Journal of the American Heart Association · 2024Article
- The food environment and hypertension: A cross-sectional analysis in Black breast cancer survivors in Maryland.Cancer epidemiology · 2024Article
- Inherent Bias in Electronic Health Records: A Scoping Review of Sources of Bias.medRxiv : the preprint server for health sciences · 2024Article
- Achieving Blood Pressure Goals and Addressing Inequities in Blood Pressure Management After Stroke.Journal of the American Heart Association · 2024Article
Corrections and comments
- Commented on by
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
Abstract
Background Observational studies demonstrate that communities of low socioeconomic status have higher blood pressure and worse cardiovascular outcomes. Yet, whether the clinical outcomes resulting from antihypertensive therapy vary by socioeconomic context in a randomized clinical trial, in which participants are treated under a standard protocol, is unknown. Methods and Results We used data from ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) to study the effect of socioeconomic context, defined as the county-level median household income, of study sites. We stratified sites into income quintiles and compared characteristics, blood pressure control, and cardiovascular outcomes among ALLHAT participants in the lowest- and highest-income quintiles. Among 27 862 qualifying participants, 2169 (7.8%) received care in the lowest-income sites (quintile 1) and 10 458 (37.6%) received care in the highest-income sites (quintile 5). Participants in quintile 1 were more likely to be women, to be black, to be Hispanic, to have fewer years of education, to live in the South, and to have fewer cardiovascular risk factors. After adjusting for baseline demographic and clinical characteristics, quintile 1 participants were less likely to achieve blood pressure control (<140/90 mm Hg) (odds ratio, 0.48; 95% CI, 0.37-0.63) and had greater all-cause mortality (hazard ratio [HR], 1.25; 95% CI, 1.10-1.41), heart failure hospitalizations/mortality (HR, 1.26; 95% CI, 1.03-1.55), and end-stage renal disease (HR, 1.86; 95% CI, 1.26-2.73), but lower angina hospitalizations (HR, 0.70; 95% CI, 0.59-0.83) and coronary revascularizations (HR, 0.71; 95% CI, 0.57-0.89). Conclusions Despite standardized treatment protocols, ALLHAT participants in the lowest-income sites experienced poorer blood pressure control and worse outcomes for some adverse cardiovascular events, emphasizing the importance of measuring and addressing socioeconomic context. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000542.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.